- Global Pharma News & Resources

Ketorolac Market, 2021-2027 by Segmentation: Based on Product, Application and Region

The Ketorolac Market report gives a weighty source to assess the market and other fundamental technicalities identifying with it. The examination unveils the total assessment and veritable parts of the Ketorolac Market. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data which enhances the understanding, scope and application of this report.The trends and expected prospects for the market are also included in the report which provides an intellectual understanding of the Ketorolac industry. Furthermore, the report quantifies the market share held by the significant players of the industry and gives an in-depth view of the competitive landscape. This market is classified into different segments with a comprehensive analysis of each with respect to a geography for the research period.

Request Here For PDF Brochure 

Impact of COVID-19 epidemic

With its impact on several markets, the COVID-19 epidemic is also expected to hinder growth of the global ketorolac market over the forecast period. Furthermore, the recommended safety measures by the World Health Organization (WHO) to minimize the transmission of SARS-CoV-2 virus and imposition of global lockdowns has majorly influenced the distribution chain of ketorolac and pharmaceutical organizations, and has resulted in higher shipping costs with decreased supply containers.


This market involves the treatment of severe to mild pain by using the NSAID (non-steroidal and anti-inflammatory drug) known as ketorolac which is controlled by parental, topical and oral route of regulation in the human body. Generally, the ketorolac is used in treatments of short duration and is recommended by the physicians to carrying-out treatments within a week. Owing to its anti-inflammatory, analgesic and anti-pyretic characteristics, the ketorolac is used as an inhibitor of prostaglandin synthesis to aid reduction in shrinkage of sensitive muscles in the human body.


Ketorolac has unique clinical applications such as its addition with paracetamol helps in controlling pain without influencing the respiration system in infants, in eye drops to reduce pain in patients after the eye surgery, and in diagnosing dysmenorrhea. In 2017, the Cycle Pharmaceutical had announced the approval of its 30mg/ml ketorolac tro-methamine injection as an Abbreviated New Drug Application by the United States Food Drug and Administration.


For human beings, the ketorolac dosing frequency is just for 5 days, in case the dosage of ketorolac is extended beyond 5 days, it may lead to serious side effects such as ulcers, coagulation disorders and gastro-intestinal bleeding. Hence, utilization of ketorolac for limited period of time in mild pains is expected to refrain growth of the global ketorolac market.

Regional Analysis

Due to the focus of key pharmaceutical companies on launch of products in NSAID for administration of critical and mild pain, the North American region is expected to experience a robust growth in the global ketorolac market. In 2018, the Nephron Pharmaceuticals Corporation had introduced BKK, a novel opioid free analgesic drug with other drug contents of Ketorolac, ketamine and Bupivacaine.

The pharmaceutical organizations in the European region are focused on approval of their respective products to bolster their share in the global ketorolac market. In 2018, Omerous Corporation had announced the approval by the European Medical Agency for distribution of its phenylephrine and ketorolac solution as an intraocular solution.

Market Taxonomy:

  • According to the formulation, the global ketorolac market is classified into:




  • According to the indication, the global ketorolac market is classified into:



Surgery Pain.



  • According to the region, the global ketorolac market is classified into:

North America

Latin America


Asia Pacific

Middle East


Major Key Players Include In Ketorolac Market: Allergan plc, Deepcare Health Pvt Ltd, Cadila Healthcare Limited, Intas Pharmaceuticals Limited, Ranbaxy Laboratories Limited, Omeros Corporation, Nephron Pharmaceuticals Corporation, Cycle Pharmaceuticals Ltd, and Neon Laboratories Limited.

Buy instant copy of this research report with Flat US $ 2000 Off@ –

Main points in Ketorolac Market Report Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Ketorolac Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Ketorolac Industry Impact

Chapter 2 Global Ketorolac Competition by Types, Applications, and Top Regions and Countries
2.1 Global Ketorolac (Volume and Value) by Type
2.3 Global Ketorolac (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Ketorolac Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Ketorolac Market Analysis
Chapter 6 East Asia Ketorolac Market Analysis
Chapter 7 Europe Ketorolac Market Analysis
Chapter 8 South Asia Ketorolac Market Analysis
Chapter 9 Southeast Asia Ketorolac Market Analysis
Chapter 10 Middle East Ketorolac Market Analysis
Chapter 11 Africa Ketorolac Market Analysis
Chapter 12 Oceania Ketorolac Market Analysis
Chapter 13 South America Ketorolac Market Analysis
Chapter 14 Company Profiles and Key Figures in Ketorolac Business
Chapter 15 Global Ketorolac Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology

Request for a Sample Report

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 17-Aug-2021